NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $530,000 | +113.7% | 6,707 | +103.2% | 0.03% | +4.0% |
| Q4 2021 | $248,000 | -35.2% | 3,300 | 0.0% | 0.02% | -43.2% |
| Q3 2021 | $383,000 | -2.5% | 3,300 | +10.9% | 0.04% | -22.8% |
| Q2 2021 | $393,000 | 0.0% | 2,975 | 0.0% | 0.06% | -18.6% |
| Q1 2021 | $393,000 | -36.9% | 2,975 | -17.4% | 0.07% | -43.1% |
| Q4 2020 | $623,000 | +63.5% | 3,600 | +5.1% | 0.12% | +30.9% |
| Q3 2020 | $381,000 | +62.8% | 3,425 | -13.3% | 0.09% | +30.6% |
| Q2 2020 | $234,000 | -45.3% | 3,950 | -37.8% | 0.07% | -52.9% |
| Q1 2020 | $428,000 | -20.0% | 6,350 | 0.0% | 0.15% | +3.4% |
| Q4 2019 | $535,000 | – | 6,350 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |